ResMed Inc Stock News

SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2023 on Thursday,

Home Depot, Merck, Bank of America, Elevance Health and ResMed are included in this Analyst Blog.

Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Merck & Co., Inc. (MRK) and Bank of America Corporation (BAC).

SAN DIEGO, Jan. 02, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on

Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see companies with upcoming ex-dividend dates and pay dates.

-  Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market

Michael Farrell of Resmed discusses the company's growth strategy after opening its largest advanced manufacturing plant in Singapore.

SINGAPORE, Nov. 17, 2022 (GLOBE NEWSWIRE) -- ResMed this week celebrated the grand opening of its new Advanced Manufacturing Centre in Tuas, Singapore.

ResMed is a potential opportunity for retail value investors to profit from this low-risk market leader, but there are several issues that worry us - the share price is high. The company revenue consi

U.S. medical device equities have not been a source of safety or growth in 2022. ResMed's diversified businesses help its earnings growth outlook through 2025. The PEG ratio looks attractive.

I filtered a watchlist of the highest quality dividend growth companies by proximity to 52-week lows. Read more to see my analysis on Microsoft here.

ResMed (RMD) continues to increase its access to semiconductor communications chips.

ResMed (RMD) continues to increase its access to semiconductor communications chips.

Plus a look at investing books, stocks to watch, and other topics for investors.

ResMed (RMD) delivered earnings and revenue surprises of 0% and 0.75%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?